Afschin Gandjour. Show Affiliations »
Abstract
Mesh: See more » Cost-Benefit Analysis/methodsHumansQuality-Adjusted Life YearsResearch DesignRisk
Year: 2008 PMID: 18793035 DOI: 10.2165/00019053-200826100-00008
Source DB: PubMed Journal: Pharmacoeconomics ISSN: 1170-7690 Impact factor: 4.981